Latest News

Lytix Biopharma AS announces dosing of first patient in a Phase II study

Lytix Biopharma presented at the Investival showcase at the Jefferies Healthcare Conference in London

Lytix Biopharma announces positive top-line data from a Phase 1 study with LTX-315

Lytix Biopharma is covered in Norwegian Airline`s magazine